Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Paramount Names Skydance Leadership as Merger Set to Close
07:51

S&P 500 Edges Closer to Record, Shrugging Off Bond & Oil Risks
36:20

US Jobs Report Eases Fed Hike Worries
44:10